The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global EGFR Mutation Test Market Research Report 2025

Global EGFR Mutation Test Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1429481

No of Pages : 83

Ask Your Query
Synopsis
Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.
The global EGFR Mutation Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.
This report aims to provide a comprehensive presentation of the global market for EGFR Mutation Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EGFR Mutation Test.
Report Scope
The EGFR Mutation Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global EGFR Mutation Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the EGFR Mutation Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Merck
Thermo Fisher Scientific
Illumina
BioMerieux
QIAGEN
Agilent Technologies
Hologic
Novartis
Roche
Genomic Health
Segment by Type
DNA Sequencing
Kits
Segment by Application
Cancer Hospitals
Clinical Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of EGFR Mutation Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global EGFR Mutation Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DNA Sequencing
1.2.3 Kits
1.3 Market by Application
1.3.1 Global EGFR Mutation Test Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer Hospitals
1.3.3 Clinical Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global EGFR Mutation Test Market Perspective (2019-2030)
2.2 EGFR Mutation Test Growth Trends by Region
2.2.1 Global EGFR Mutation Test Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 EGFR Mutation Test Historic Market Size by Region (2019-2024)
2.2.3 EGFR Mutation Test Forecasted Market Size by Region (2025-2030)
2.3 EGFR Mutation Test Market Dynamics
2.3.1 EGFR Mutation Test Industry Trends
2.3.2 EGFR Mutation Test Market Drivers
2.3.3 EGFR Mutation Test Market Challenges
2.3.4 EGFR Mutation Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top EGFR Mutation Test Players by Revenue
3.1.1 Global Top EGFR Mutation Test Players by Revenue (2019-2024)
3.1.2 Global EGFR Mutation Test Revenue Market Share by Players (2019-2024)
3.2 Global EGFR Mutation Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by EGFR Mutation Test Revenue
3.4 Global EGFR Mutation Test Market Concentration Ratio
3.4.1 Global EGFR Mutation Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by EGFR Mutation Test Revenue in 2023
3.5 EGFR Mutation Test Key Players Head office and Area Served
3.6 Key Players EGFR Mutation Test Product Solution and Service
3.7 Date of Enter into EGFR Mutation Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 EGFR Mutation Test Breakdown Data by Type
4.1 Global EGFR Mutation Test Historic Market Size by Type (2019-2024)
4.2 Global EGFR Mutation Test Forecasted Market Size by Type (2025-2030)
5 EGFR Mutation Test Breakdown Data by Application
5.1 Global EGFR Mutation Test Historic Market Size by Application (2019-2024)
5.2 Global EGFR Mutation Test Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America EGFR Mutation Test Market Size (2019-2030)
6.2 North America EGFR Mutation Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America EGFR Mutation Test Market Size by Country (2019-2024)
6.4 North America EGFR Mutation Test Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe EGFR Mutation Test Market Size (2019-2030)
7.2 Europe EGFR Mutation Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe EGFR Mutation Test Market Size by Country (2019-2024)
7.4 Europe EGFR Mutation Test Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific EGFR Mutation Test Market Size (2019-2030)
8.2 Asia-Pacific EGFR Mutation Test Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific EGFR Mutation Test Market Size by Region (2019-2024)
8.4 Asia-Pacific EGFR Mutation Test Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America EGFR Mutation Test Market Size (2019-2030)
9.2 Latin America EGFR Mutation Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America EGFR Mutation Test Market Size by Country (2019-2024)
9.4 Latin America EGFR Mutation Test Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa EGFR Mutation Test Market Size (2019-2030)
10.2 Middle East & Africa EGFR Mutation Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa EGFR Mutation Test Market Size by Country (2019-2024)
10.4 Middle East & Africa EGFR Mutation Test Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott EGFR Mutation Test Introduction
11.1.4 Abbott Revenue in EGFR Mutation Test Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck EGFR Mutation Test Introduction
11.2.4 Merck Revenue in EGFR Mutation Test Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific EGFR Mutation Test Introduction
11.3.4 Thermo Fisher Scientific Revenue in EGFR Mutation Test Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina EGFR Mutation Test Introduction
11.4.4 Illumina Revenue in EGFR Mutation Test Business (2019-2024)
11.4.5 Illumina Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Detail
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux EGFR Mutation Test Introduction
11.5.4 BioMerieux Revenue in EGFR Mutation Test Business (2019-2024)
11.5.5 BioMerieux Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Detail
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN EGFR Mutation Test Introduction
11.6.4 QIAGEN Revenue in EGFR Mutation Test Business (2019-2024)
11.6.5 QIAGEN Recent Development
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Detail
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies EGFR Mutation Test Introduction
11.7.4 Agilent Technologies Revenue in EGFR Mutation Test Business (2019-2024)
11.7.5 Agilent Technologies Recent Development
11.8 Hologic
11.8.1 Hologic Company Detail
11.8.2 Hologic Business Overview
11.8.3 Hologic EGFR Mutation Test Introduction
11.8.4 Hologic Revenue in EGFR Mutation Test Business (2019-2024)
11.8.5 Hologic Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis EGFR Mutation Test Introduction
11.9.4 Novartis Revenue in EGFR Mutation Test Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche EGFR Mutation Test Introduction
11.10.4 Roche Revenue in EGFR Mutation Test Business (2019-2024)
11.10.5 Roche Recent Development
11.11 Genomic Health
11.11.1 Genomic Health Company Detail
11.11.2 Genomic Health Business Overview
11.11.3 Genomic Health EGFR Mutation Test Introduction
11.11.4 Genomic Health Revenue in EGFR Mutation Test Business (2019-2024)
11.11.5 Genomic Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global EGFR Mutation Test Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of DNA Sequencing
Table 3. Key Players of Kits
Table 4. Global EGFR Mutation Test Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global EGFR Mutation Test Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global EGFR Mutation Test Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global EGFR Mutation Test Market Share by Region (2019-2024)
Table 8. Global EGFR Mutation Test Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global EGFR Mutation Test Market Share by Region (2025-2030)
Table 10. EGFR Mutation Test Market Trends
Table 11. EGFR Mutation Test Market Drivers
Table 12. EGFR Mutation Test Market Challenges
Table 13. EGFR Mutation Test Market Restraints
Table 14. Global EGFR Mutation Test Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global EGFR Mutation Test Market Share by Players (2019-2024)
Table 16. Global Top EGFR Mutation Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EGFR Mutation Test as of 2023)
Table 17. Ranking of Global Top EGFR Mutation Test Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by EGFR Mutation Test Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players EGFR Mutation Test Product Solution and Service
Table 21. Date of Enter into EGFR Mutation Test Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global EGFR Mutation Test Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global EGFR Mutation Test Revenue Market Share by Type (2019-2024)
Table 25. Global EGFR Mutation Test Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global EGFR Mutation Test Revenue Market Share by Type (2025-2030)
Table 27. Global EGFR Mutation Test Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global EGFR Mutation Test Revenue Market Share by Application (2019-2024)
Table 29. Global EGFR Mutation Test Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global EGFR Mutation Test Revenue Market Share by Application (2025-2030)
Table 31. North America EGFR Mutation Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America EGFR Mutation Test Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America EGFR Mutation Test Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe EGFR Mutation Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe EGFR Mutation Test Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe EGFR Mutation Test Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific EGFR Mutation Test Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific EGFR Mutation Test Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific EGFR Mutation Test Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America EGFR Mutation Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America EGFR Mutation Test Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America EGFR Mutation Test Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa EGFR Mutation Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa EGFR Mutation Test Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa EGFR Mutation Test Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbott Company Detail
Table 47. Abbott Business Overview
Table 48. Abbott EGFR Mutation Test Product
Table 49. Abbott Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. Merck Company Detail
Table 52. Merck Business Overview
Table 53. Merck EGFR Mutation Test Product
Table 54. Merck Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Thermo Fisher Scientific Company Detail
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific EGFR Mutation Test Product
Table 59. Thermo Fisher Scientific Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Illumina Company Detail
Table 62. Illumina Business Overview
Table 63. Illumina EGFR Mutation Test Product
Table 64. Illumina Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
Table 65. Illumina Recent Development
Table 66. BioMerieux Company Detail
Table 67. BioMerieux Business Overview
Table 68. BioMerieux EGFR Mutation Test Product
Table 69. BioMerieux Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
Table 70. BioMerieux Recent Development
Table 71. QIAGEN Company Detail
Table 72. QIAGEN Business Overview
Table 73. QIAGEN EGFR Mutation Test Product
Table 74. QIAGEN Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
Table 75. QIAGEN Recent Development
Table 76. Agilent Technologies Company Detail
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies EGFR Mutation Test Product
Table 79. Agilent Technologies Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
Table 80. Agilent Technologies Recent Development
Table 81. Hologic Company Detail
Table 82. Hologic Business Overview
Table 83. Hologic EGFR Mutation Test Product
Table 84. Hologic Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
Table 85. Hologic Recent Development
Table 86. Novartis Company Detail
Table 87. Novartis Business Overview
Table 88. Novartis EGFR Mutation Test Product
Table 89. Novartis Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. Roche Company Detail
Table 92. Roche Business Overview
Table 93. Roche EGFR Mutation Test Product
Table 94. Roche Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
Table 95. Roche Recent Development
Table 96. Genomic Health Company Detail
Table 97. Genomic Health Business Overview
Table 98. Genomic Health EGFR Mutation Test Product
Table 99. Genomic Health Revenue in EGFR Mutation Test Business (2019-2024) & (US$ Million)
Table 100. Genomic Health Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global EGFR Mutation Test Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global EGFR Mutation Test Market Share by Type: 2023 VS 2030
Figure 3. DNA Sequencing Features
Figure 4. Kits Features
Figure 5. Global EGFR Mutation Test Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global EGFR Mutation Test Market Share by Application: 2023 VS 2030
Figure 7. Cancer Hospitals Case Studies
Figure 8. Clinical Research Institutes Case Studies
Figure 9. EGFR Mutation Test Report Years Considered
Figure 10. Global EGFR Mutation Test Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global EGFR Mutation Test Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global EGFR Mutation Test Market Share by Region: 2023 VS 2030
Figure 13. Global EGFR Mutation Test Market Share by Players in 2023
Figure 14. Global Top EGFR Mutation Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EGFR Mutation Test as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by EGFR Mutation Test Revenue in 2023
Figure 16. North America EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America EGFR Mutation Test Market Share by Country (2019-2030)
Figure 18. United States EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe EGFR Mutation Test Market Share by Country (2019-2030)
Figure 22. Germany EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific EGFR Mutation Test Market Share by Region (2019-2030)
Figure 30. China EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America EGFR Mutation Test Market Share by Country (2019-2030)
Figure 38. Mexico EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa EGFR Mutation Test Market Share by Country (2019-2030)
Figure 42. Turkey EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia EGFR Mutation Test Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Abbott Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
Figure 45. Merck Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
Figure 47. Illumina Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
Figure 48. BioMerieux Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
Figure 49. QIAGEN Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
Figure 50. Agilent Technologies Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
Figure 51. Hologic Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
Figure 52. Novartis Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
Figure 53. Roche Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
Figure 54. Genomic Health Revenue Growth Rate in EGFR Mutation Test Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock